‘Scamazon’ – how fake emails are targeting Prime subscribers

Jefferies, a major financial firm, has bumped up its price target for Avenue Supermarts—the company behind DMart—from ₹4,100 to ₹4,200 per share. This suggests they’re feeling more optimistic about the stock’s growth potential, likely due to strong performance or favorable market conditions.

Editor’s Note: For investors, this is a signal that analysts see DMart’s parent company as a solid bet. Price target hikes often reflect confidence in a business, whether it’s due to earnings, expansion plans, or sector trends. If you’re holding DMart shares or eyeing them, this could be a nudge to pay attention—though, as always, it’s just one piece of the puzzle.

Warner Bros. is flying high thanks to its latest blockbuster, Superman, which raked in a whopping $217 million over the weekend. This caps off an impressive streak—five back-to-back hits—marking a major comeback for the studio after some rough patches.

Editor’s Note: After a string of box-office disappointments, Warner Bros. has finally found its footing again. A successful run like this doesn’t just boost profits—it rebuilds confidence in the studio’s ability to deliver crowd-pleasers. For movie fans, it’s a sign that big-budget films can still pack theaters when they get it right.

A prime piece of real estate on the Las Vegas Strip is hitting the market—an unusual event since these coveted properties rarely go up for sale. This one might even be auctioned off, adding to the intrigue.

Editor’s Note: The Las Vegas Strip is one of the most high-profile real estate markets in the world, so any sale here is a big deal. It could signal shifting fortunes for the casino and hospitality industry, or just a rare chance for a deep-pocketed investor to grab a legendary location. Either way, it’s worth watching.

The US Federal Aviation Administration (FAA) and Boeing have reportedly confirmed that the fuel switch locks on certain aircraft are safe, according to internal documents and sources. This comes as Air India faces scrutiny over its own investigation into potential safety issues. Essentially, regulators and the manufacturer are signaling there’s no immediate risk—but the timing raises eyebrows given the ongoing probe.

Editor’s Note: For travelers and airlines, this is a quiet reassurance—but not an all-clear. The FAA and Boeing’s stance suggests the hardware isn’t faulty, but the fact that this had to be clarified mid-investigation hints at lingering concerns behind the scenes. It’s a reminder of how tightly aviation safety and public trust are intertwined, especially after recent industry turbulence.

BofA Securities is betting big on Caris Life Sciences, giving the company's stock a shiny new "Buy" rating in its first-ever coverage. Analysts seem optimistic about the biotech firm's potential, though they didn't spill many details on why.

Editor’s Note: When a heavyweight like BofA gives a thumbs-up to a stock, investors pay attention—especially in the volatile biotech sector. This could mean fresh momentum for Caris, whether it's due to promising research, strong leadership, or just Wall Street seeing dollar signs. Either way, it’s a signal worth watching if you’re tracking healthcare innovation or stock moves.